vimarsana.com

Latest Breaking News On - Maha katabi - Page 2 : vimarsana.com

Vera Therapeutics (NASDAQ:VERA) Issues Quarterly Earnings Results

Vera Therapeutics (NASDAQ:VERA) Issues Quarterly Earnings Results
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Josephr-young
Raymond-james
Maha-katabi
Vera-therapeutics-company-profile
Vera-therapeutics-inc
Vera-therapeutics
Get-free-report
Therapeutics-stock-down
Director-maha-katabi
Vera-therapeutics-daily

Vera Therapeutics (NASDAQ:VERA) Sees Large Volume Increase

Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) saw strong trading volume on Thursday . 980,711 shares traded hands during trading, a decline of 21% from the previous session’s volume of 1,245,474 shares.The stock last traded at $43.49 and had previously closed at $41.62. Analysts Set New Price Targets A number of equities analysts have […]

Canada
Raymond-james
Maha-katabi
Royal-bank
Vera-therapeutics-company-profile
Nasdaq
Vera-therapeutics-inc
Securities-exchange-commission
Ameritas-investment-partners-inc
Tower-research-capital
Vera-therapeutics
Get-free-report

Vera Therapeutics (NASDAQ:VERA) Earns Buy Rating from Guggenheim

Guggenheim reaffirmed their buy rating on shares of Vera Therapeutics (NASDAQ:VERA – Free Report) in a research report released on Friday, Benzinga reports. They currently have a $56.00 price target on the stock. Several other brokerages have also commented on VERA. Raymond James raised Vera Therapeutics from an outperform rating to a strong-buy rating and […]

Raymond-james
Maha-katabi
Cantor-fitzgerald
Barclays-plc
Vanguard-group-inc
Capital-partners
Goldman-sachs-group-inc
Vera-therapeutics-inc
Vera-therapeutics
Free-report
Director-maha-katabi
Sachs-group

Vera Therapeutics (NASDAQ:VERA) Shares Gap Down on Insider Selling

Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report)’s share price gapped down before the market opened on Monday after an insider sold shares in the company. The stock had previously closed at $37.52, but opened at $36.63. Vera Therapeutics shares last traded at $37.81, with a volume of 45,552 shares traded. Specifically, Director Maha Katabi […]

Canada
Maha-katabi
Raymond-james
Royal-bank
Vera-therapeutics-inc
Tower-research-capital
Ameritas-investment-partners-inc
Nasdaq
Cantor-fitzgerald
Vera-therapeutics-company-profile
Vera-therapeutics
Get-free-report

Guggenheim Reiterates Buy Rating for Vera Therapeutics (NASDAQ:VERA)

Guggenheim Reiterates Buy Rating for Vera Therapeutics (NASDAQ:VERA)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada
Maha-katabi
Raymond-james
Cantor-fitzgerald
Securities-exchange-commission
Ameritas-investment-partners-inc
Tower-research-capital
Royal-bank
Vera-therapeutics-inc
Vera-therapeutics
Get-free-report
Director-maha-katabi
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.